BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//bioethics.com - ECPv6.18.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://bioethics.com
X-WR-CALDESC:Events for bioethics.com
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261009T120000
DTEND;TZID=America/New_York:20261009T130000
DTSTAMP:20261007T221349Z
CREATED:20261007T221349Z
LAST-MODIFIED:20261007T221349Z
UID:104350-1791547200-1791550800@bioethics.com
SUMMARY:What Do China’s Recent Gene Editing Deaths Mean for CRISPR Research?
DESCRIPTION:Abstract: In July and August 2026\, news broke revealing that two young children in China had died in gene-editing trials over a year earlier. For clinicians\, researchers\, and ELSI scholars who have tracked gene-editing developments over the last several decades\, the recent cases brought back uncomfortable memories of Jesse Gelsinger\, the teenager who died in a gene therapy trial at the University of Pennsylvania in 1999. Much progress has been made in the gene-editing field since Gelsinger’s death\, with cases like the successful treatment of Baby KJ raising the prospect of personalized\, n-of-1 trials for children born with rare genetic diseases. The deaths in China were a stark reminder of how much work still needs to be done to make experimental gene therapies reliably safe and effective\, as well as the need for close oversight and transparency in the push for progress. \nThis ELSI Friday Forum will examine the recent gene-editing deaths and the questions that they raise for gene-editing clinical research more generally: What oversight was in place for the cases in China\, and how does that system compare to other versions across the globe? Are the deaths isolated cases\, or is there a more general trend that would suggest a wider problem–and what data are available to even assess the situation? How should these tragic losses and the risk of future deaths be weighed against the promise of gene therapies? \nThis event is the second in a series of ELSI sessions devoted to gene therapy-related deaths.
URL:https://bioethics.com/event/what-do-chinas-recent-gene-editing-deaths-mean-for-crispr-research
LOCATION:Online
END:VEVENT
END:VCALENDAR